Zentalis reports survival data from azenosertib ovarian cancer study
DENALI Part 1b evaluated 102 participants who had undergone between one and five previous lines of treatment.
Clinical Trials
Cyrano’s Phase II trial of CYR-064 meets primary safety endpoint
First patient dosed in MacroGenics’ Phase I MGC030 trial
Merz concludes enrolment in Phase III Xeomin trials for migraine
Spinogenix adds Phase IIb autism study to CLARITY basket trial
Pilatus doses first patient in Phase I PLT012 trial for HCC
IgniteData, RealTime join forces to automate clinical trial data transfers
Dosing completed in Calluna Pharma’s Phase II AURORA trial
